CEP72常见及罕见遗传变异对脑肿瘤患者长春新碱诱导周围神经病变的贡献
本研究在104例接受长春新碱治疗的脑肿瘤患者中评估CEP72 rs924607与周围神经病变的关联,并对CEP72编码区进行测序。
要点
- 脑肿瘤患者中CEP72 rs924607与长春新碱神经病变单队列关联不显著。
- 跨疾病荟萃分析中TT基因型显著增加神经病变风险(OR 2.15)。
- CEP72编码区其他变异(如rs12522955)可能与神经病变相关。
核心结论
- CEP72 rs924607与长春新碱诱导周围神经病变的关联在脑肿瘤患者队列中未获确认,但在跨疾病荟萃分析中支持其效应。
- CEP72其他遗传变异对长春新碱诱导神经病变的重要性得到证实。
研究设计与样本
- 研究纳入104例接受长春新碱治疗的脑肿瘤患者,对CEP72 rs924607进行基因分型并对蛋白编码区测序。
- 收集患者特征、治疗特征及周围神经病变数据,采用逻辑回归和荟萃分析进行rs924607重复验证。
- 应用加权负荷分析评估CEP72整体遗传变异的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Studies implicated a role for a genetic variant in CEP72 in vincristine-induced peripheral neuropathy. This study aims to evaluate this association in a cohort of brain tumour patients, to perform a cross-disease meta-analysis and explore the protein-coding region of CEP72. METHODS: In total, 104 vincristine-treated brain tumour patients were genotyped for CEP72 rs924607, and sequenced for the protein-coding region. Data regarding patient and treatment characteristics, and peripheral neuropathy, were collected. Logistic regression and meta-analysis were performed for rs924607 replication. A weighted burden analysis was applied to evaluate impact of overall genetic variation in CEP72. RESULTS: Analysis of 24 cases and 80 controls did not show a significant association between CEP72 rs924607 and neuropathy (odds ratio, OR [95% confidence interval, CI] 2.076 [0.359-11.989], P = .414). When combined with 8 cohorts (1095 cancer patients), a significant increase in risk for neuropathy was found for patients with a TT genotype (OR [95% CI] 2.15 [1.35-3.43], P = .001). Additionally, a missense variant (rs12522955) was significantly associated (OR [95% CI] 2.3 [1.2-4.4], P = .041) and patients with severe neuropathy carried more impactful variants in CEP72 coding regions (P = .039). CONCLUSION: The association of CEP72 rs924607 in vincristine-induced neuropathy was not confirmed in a cohort of brain tumour patients, but did contribute to its suggested effect when combined in a cross-disease meta-analysis. The importance of other genetic variations in CEP72 on vincristine-induced neuropathy was demonstrated. This study contributes to evidence of the importance of genetic variants in CEP72 in development of vincristine-induced toxicity, and provides guidance for future prospective studies.
引用
- Klumpers MJ, Brand ACAM, Hakobjan M, et al. Contribution of common and rare genetic variants in CEP72 on vincristine-induced peripheral neuropathy in brain tumour patients. Br J Clin Pharmacol. 2022. PMID: 35150001. doi:10.1111/bcp.15267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。